// App-Quantinova.ai

FRI0203 : Sustained Drug Free Remission in Early Ra Patients Treated To Target with Tocilizumab, Methotrexate or Their Combination

Researchers

Presenter

  • X.M. Teitsma

Principal Investigators

  • J.W. Jacobs

  • P.M. Welsing

  • T.G. Woodworth

  • A. Petho-Schramm

  • M.E. Borm

  • C. Bernasconi

  • F.P. Lafeber

  • J.W. Bijlsma

Medical Centers

  • Rheumatology and Clinical Immunology, ARC Amsterdam; UMC Utrecht, Utrecht, Netherlands

Locations

  • Netherlands

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Tocilizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved